Guggenheim Capital’s Beam Therapeutics BEAM Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $574K | Sell |
33,731
-5,918
| -15% | -$101K | ﹤0.01% | 1111 |
|
|
2025
Q1 | $774K | Buy |
39,649
+3,822
| +11% | +$74.6K | 0.01% | 989 |
|
|
2024
Q4 | $889K | Sell |
35,827
-6,818
| -16% | -$169K | 0.01% | 971 |
|
|
2024
Q3 | $1.04M | Sell |
42,645
-4,434
| -9% | -$109K | 0.01% | 1077 |
|
|
2024
Q2 | $1.1M | Sell |
47,079
-1,316
| -3% | -$30.8K | 0.01% | 1071 |
|
|
2024
Q1 | $1.6M | Sell |
48,395
-3,208
| -6% | -$106K | 0.01% | 973 |
|
|
2023
Q4 | $1.4M | Sell |
51,603
-18,390
| -26% | -$501K | 0.01% | 991 |
|
|
2023
Q3 | $1.68M | Sell |
69,993
-16,349
| -19% | -$393K | 0.01% | 871 |
|
|
2023
Q2 | $2.76M | Buy |
86,342
+5,104
| +6% | +$163K | 0.02% | 727 |
|
|
2023
Q1 | $2.49M | Sell |
81,238
-6,620
| -8% | -$203K | 0.02% | 773 |
|
|
2022
Q4 | $3.44M | Buy |
87,858
+328
| +0.4% | +$12.8K | 0.03% | 653 |
|
|
2022
Q3 | $4.17M | Sell |
87,530
-9,409
| -10% | -$448K | 0.04% | 575 |
|
|
2022
Q2 | $3.75M | Buy |
96,939
+5,603
| +6% | +$217K | 0.03% | 661 |
|
|
2022
Q1 | $5.23M | Buy |
91,336
+2,182
| +2% | +$125K | 0.03% | 631 |
|
|
2021
Q4 | $7.1M | Buy |
89,154
+16,846
| +23% | +$1.34M | 0.04% | 542 |
|
|
2021
Q3 | $6.29M | Buy |
72,308
+47,463
| +191% | +$4.13M | 0.04% | 563 |
|
|
2021
Q2 | $3.2M | Buy |
+24,845
| New | +$3.2M | 0.02% | 851 |
|